Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review : Anti-Cancer Drugs

Journal Logo

Case Reports

Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review

Wang, Hao; He, Yang; Zhao, Weipeng; Tong, Zhongsheng

Author Information
Anti-Cancer Drugs 33(8):p 773-777, September 2022. | DOI: 10.1097/CAD.0000000000001369

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid